"As far as I am aware, no currently approved wound care treatments have been through a double blinded prospective randomised control trial."
This is what a double blinded study is: http://www.mendosa.com/bratman.htm
Randomized controlled trial (the diagram explains best): http://en.wikipedia.org/wiki/Randomized_controlled_trial
prospective study: an epidemiologic study in which the groups of individuals (cohorts) are selected on the bases of factors that are to be examined for possible effects on some outcome. For example, the effect of exposure to a specific risk factor on the eventual development of a particular disease can be studied. The cohorts are then followed over a period of time to determine the incidence rates of the outcomes being studied as they relate to the original factors in question. Called also cohort study.
I especially like this quote from mercer: "in all clinical trials to date there has not been a single adverse event related to VitroGro®"
This is because as a long term holder, I wish that the product offers signficant marketability and especially, in health care has little risk of future legal suits or product callbacks. Look at COH for an example last year, they lost billions from the problems of the implaint failure.
TIS Price at posting:
46.5¢ Sentiment: Buy Disclosure: Held